Benorterone

From WikiMD.org
Jump to navigation Jump to search

Benorterone

Benorterone (pronounced: ben-or-ter-one) is a synthetic, steroidal antiandrogen that was studied in the late 1960s and early 1970s but was never marketed. It is a steroid that has been found to act as an androgen receptor antagonist.

Etymology

The term "Benorterone" is derived from the chemical name benzo[d][1,3]dioxol-5-ylmethyl (1R,3aS,3bR,9aR,9bS,11aS)-7-hydroxy-8,8,9a,3a-tetramethyl-2-oxo-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[a]phenanthren-1-yl ether.

Related Terms

  • Steroid: A type of organic compound that contains a characteristic arrangement of four cycloalkane rings that are joined to each other.
  • Androgen receptor: A type of nuclear receptor that is activated by binding any of the androgenic hormones, including testosterone and dihydrotestosterone in the cytoplasm and then translocating into the nucleus.
  • Antiandrogen: A substance that prevents or inhibits the biological effects of androgen hormones in the body.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski